MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2024 International Congress

    A Study of Age-related Changes in Galanin Expression in the Neuropil and Associated Boutons in the Human Locus Coeruleus.

    S. Banik, A. Bhattacharya, A. Mahadevan, Y. Tc, P. Alladi (Bengaluru, India)

    Objective: To determine the age-effects on galanin (Gal)-enriched synaptic boutons and neuropil of human locus coeruleus (LC) using autopsied human tissues. Background: The LC has…
  • 2024 International Congress

    Can We Rid Uganda of the Societal Myth That Parkinson’s Disease Is Witchcraft?

    S. Klingelhofer, H. Tamale, G. Mogan (Tillamook, USA)

    Objective: Educate rural Ugandans that Parkinson’s Disease (PD) is a scientific disorder, not contagious or the result of anything mystical Background: People with PD (PWP)…
  • 2024 International Congress

    Combined application of alpha-synuclein and 4-repeat tau seed amplification assays for the differential diagnosis of parkinsonian disorders

    E. Jabbari, E. Artikis, C. Orru`, D. Vaughan, N. Vijiaratnam, R. Fumi, M. Theilmann Jensen, M. Hodgson, T. Georgiades, L. Wu, D. Lux, R. Obrocki, B. Groveman, A. Hughson, O. Ansorge, K. Allinson, T. Warner, Z. Jaunmuktane, A. Misbahuddin, N. Leigh, B. Ghosh, K. Bhatia, A. Church, C. Kobylecki, M. Hu, J. Rowe, C. Blauwendraat, T. Foltynie, H. Morris, B. Caughey (London, United Kingdom)

    Objective: To assess alpha-synuclein (a-syn) and 4-repeat tau (4RT) seed amplification assay (SAA) positivity rates in biosamples from people with Parkinson’s disease (PD) and Progressive…
  • 2024 International Congress

    Preventing Treatment Disruptions: The Crucial Role of Outpatient Nurses and Multidisciplinary Collaboration in Managing Skin Complications during Foslevodopa/Foscarbidopa Therapy

    T. Kojiri, N. Nishikawa, Y. Uchida, M. Nozaki, N. Yoshihara, S. Ueno, G. Oyama, T. Hatano, N. Hattori (Tokyo, Japan)

    Objective: The objective of this research was to explore the pivotal role of outpatient nurses in mitigating skin complications and facilitating uninterrupted treatment for Parkinson's…
  • 2024 International Congress

    Baseline and Longitudinal NSD-ISS Staging of the PPMI Cohort

    M. Brumm, T. Simuni, C. Gochanour, L. Chahine, K. Poston, S. Chowdhury, C. Coffey, T. Dam, P. Dibiaso, T. Foroud, M. Fraiser, K. Kieburtz, C. Kopil, K. Merchant, B. Mollenhauer, G. Pagano, J. Seibyl, T. Sherer, D. Stephenson, C. Tanner, E. Tolosa, D. Weintraub, Y. Xiao, A. Siderowf, B. Dunn, K. Marek (Iowa City, USA)

    Objective: To apply biological definition and Neuronal α-Synuclein Disease Integrated Staging System (NSD-ISS) to the PPMI baseline and longitudinal dataset. Background: The NSD-ISS Working Group…
  • 2024 International Congress

    The impact of stimulation setting on Battery Longevity in Deep Brain Stimulation

    F. Yazdanian, A. Enriquez-Marulanda, N. Dehmamy, J. Shils, R. Alterman (boston, USA)

    Objective: This study aims to assess the estimated battery longevity and its determinants in Percept model of Deep Brain Stimulation (DBS) devices in patients diagnosed…
  • 2024 International Congress

    Association between Parkinsonism, Parkinson’s Disease and Cognitive Impairment and Incidence of Dementia in People with Parkinsonism and Parkinson’s Disease in Latin America: A 10/66 Dementia Research Group Study

    N. Khan, M. Arruabarrena, D. Kim, M. Jiang, J. Llibre-Rodriguez, A. Salgado, I. Acosta, A. Sosa, D. Acosta, I. Jimenez-Velasquez, M. Guerra, A. Salas, L. Contreras, H. Hesse, C. Tanner, M. Prina, J. Guerra (Newcasle Upon Tyne, United Kingdom)

    Objective: The study aimed to determine the cross-sectional and prospective associations between parkinsonism and Parkinson's disease with cognitive impairment and dementia in a large multi-country…
  • 2024 International Congress

    Incident & Prevalent Dementia in Individuals with Parkinson’s Disease in the Framingham Heart Study

    J. Dookhy, Y. Li, A. Gurnani, S. O'Shea, S. Frank, R. Au, J. Mez, Y. Liu, TFA. Ang, L. Shih (Galway, Ireland)

    Objective: To examine incident and prevalent dementia cases in individuals with Parkinson's Disease (PD) within a longitudinal population-based study Background: Longitudinal studies have found that…
  • 2024 International Congress

    Assessing the Impact of Deep Brain Stimulation on Cognitive Impairment in Parkinson’s Disease: a longitudinal study.

    K. Velázquez-Román, G. Rivera-Monroy, R. Baños-Betancourt, W. Moguel-Cardín, A. Guerra-Anzaldo, C. álvarez-Hernández, A. Domínguez-García, A. Hernández-Medrano, A. Cervantes-Arriaga, M. Rodríguez-Violante (Mexico city, Mexico)

    Objective: To longitudinally assess cognitive function post-DBS in Patients with Parkinson's Disease. Background: Parkinson's disease (PD) is a chronic neurodegenerative condition that primarily affects the…
  • 2024 International Congress

    Transcutaneous tibial nerve stimulation for overactive bladder symptoms in Parkinson’s disease: results from a phase II randomised control trial (STRIPE)

    M. Smith, A. Cullen, G. Portlock, M. Drake, Y. Ben-Shlomo, E. Henderson (Bristol, United Kingdom)

    Objective: To undertake a randomised control trial of transcutaneous tibial nerve stimulation (TTNS) delivered by Geko™ device for LUTS related to overactive bladder (OAB) symptoms…
  • « Previous Page
  • 1
  • …
  • 40
  • 41
  • 42
  • 43
  • 44
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • #23660 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • Patients with Essential Tremor Live Longer than their Relatives
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley